Figure 4

Waterfall diagram showing maximal changes of target lesions by dose levels (A) and progression-free survival (PFS) durations while on the previous regimen and on the current study treatment (B).
Waterfall diagram showing maximal changes of target lesions by dose levels (A) and progression-free survival (PFS) durations while on the previous regimen and on the current study treatment (B).